D.A. Davidson & Co.
- SEC CIK
- 0001080107
- Latest filing
- Jul 24, 2026
DXCM holding history
Dexcom Inc in every 13F filed by D.A. Davidson & Co., including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
DXCM overviewAll 13F holders of DXCMFull Q2 2026 holdings
- Shares (Q2 2026)
- 27,982
- Value
- $1.88M
- % of portfolio
- <0.1%
- Quarters held
- 22
- Since Q1 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2026 | 27,982 | $1.88M | <0.1% | +182+0.7% | Added | Holders |
| Q1 2026 | 27,800 | $1.75M | <0.1% | −776−2.7% | Reduced | Holders |
| Q4 2025 | 28,576 | $1.90M | <0.1% | −3,417−10.7% | Reduced | Holders |
| Q3 2025 | 31,993 | $2.15M | <0.1% | +2,566+8.7% | Added | Holders |
| Q2 2025 | 29,427 | $2.57M | <0.1% | +3,315+12.7% | Added | Holders |
| Q1 2025 | 26,112 | $1.78M | <0.1% | +1,323+5.3% | Added | Holders |
| Q4 2024 | 24,789 | $1.93M | <0.1% | −7,789−23.9% | Reduced | Holders |
| Q3 2024 | 32,578 | $2.18M | <0.1% | +5,969+22.4% | Added | Holders |
| Q2 2024 | 26,609 | $3.02M | <0.1% | −8,876−25.0% | Reduced | Holders |
| Q1 2024 | 35,485 | $4.92M | <0.1% | +100.0% | Added | Holders |
| Q4 2023 | 35,475 | $4.40M | <0.1% | +465+1.3% | Added | Holders |
| Q3 2023 | 35,010 | $3.27M | <0.1% | +9,432+36.9% | Added | Holders |
| Q2 2023 | 25,578 | $3.29M | <0.1% | −4,641−15.4% | Reduced | Holders |
| Q1 2023 | 30,219 | $3.51M | <0.1% | +125+0.4% | Added | Holders |
| Q4 2022 | 30,094 | $3.41M | <0.1% | −2,276−7.0% | Reduced | Holders |
| Q3 2022 | 32,370 | $2.61M | <0.1% | −1,292−3.8% | Reduced | Holders |
| Q2 2022 | 33,662 | $2.51M | <0.1% | +2,038+6.4% | AddedConverted for a 4-for-1 split | Holders |
| Q1 2022 | 7,906 | $4.04M | <0.1% | −187−2.3% | Reduced | Holders |
| Q4 2021 | 8,093 | $4.35M | <0.1% | +43+0.5% | Added | Holders |
| Q3 2021 | 8,050 | $4.40M | 0.1% | −315−3.8% | Reduced | Holders |
| Q2 2021 | 8,365 | $3.57M | <0.1% | +775+10.2% | Added | Holders |
| Q1 2021 | 7,590 | $2.73M | <0.1% | – | – | Holders |
Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.